[Heparin, thrombin and Factor Xa inhibitors].

Area of Science:

• Biochemistry
• Pharmacology
• Hematology

Context:

• Serine proteases in the coagulation system are targeted by direct and indirect inhibitors.
• Indirect inhibitors like heparins function via antithrombin and heparin cofactor II.
• These agents potentiate the inactivation of factor Xa and other serine proteases.

Purpose:

• To review the mechanisms of action for direct and indirect coagulation inhibitors.
• To discuss current and emerging anticoagulant agents and methodologies.
• To highlight advancements in managing thromboembolic diseases.

Summary:

• Coagulation inhibitors, including heparins, low-molecular-weight heparins, fondaparinux, and danaparoid, act indirectly via antithrombin.
• Direct thrombin inhibitors bind reversibly to thrombin without cofactors.
• Novel anticoagulants include oral factor Xa and thrombin inhibitors, with ongoing development in anticoagulant methods for improved specificity.

Impact:

• Improved understanding of anticoagulant mechanisms.
• Advancements in the development of novel anticoagulants for clinical use.
• Enhanced diagnostic and therapeutic strategies for thromboembolic disorders.